Format

Send to

Choose Destination
PLoS Pathog. 2014 Feb 20;10(2):e1003942. doi: 10.1371/journal.ppat.1003942. eCollection 2014 Feb.

'Death and axes': unexpected Ca²⁺ entry phenologs predict new anti-schistosomal agents.

Author information

1
Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, United States of America.
2
Department of Biomedical Sciences, Iowa State University, Ames, Iowa, United States of America.
3
Department of Chemistry, University of Minnesota, Minneapolis, Minnesota, United States of America.
4
Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, United States of America ; The Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America.

Abstract

Schistosomiasis is a parasitic flatworm disease that infects 200 million people worldwide. The drug praziquantel (PZQ) is the mainstay therapy but the target of this drug remains ambiguous. While PZQ paralyses and kills parasitic schistosomes, in free-living planarians PZQ caused an unusual axis duplication during regeneration to yield two-headed animals. Here, we show that PZQ activation of a neuronal Ca²⁺ channel modulates opposing dopaminergic and serotonergic pathways to regulate 'head' structure formation. Surprisingly, compounds with efficacy for either bioaminergic network in planarians also displayed antischistosomal activity, and reciprocally, agents first identified as antischistocidal compounds caused bipolar regeneration in the planarian bioassay. These divergent outcomes (death versus axis duplication) result from the same Ca²⁺ entry mechanism, and comprise unexpected Ca²⁺ phenologs with meaningful predictive value. Surprisingly, basic research into axis patterning mechanisms provides an unexpected route for discovering novel antischistosomal agents.

PMID:
24586156
PMCID:
PMC3930560
DOI:
10.1371/journal.ppat.1003942
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center